Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

Solborn, Inc. (035610.KQ)

Compare
3,695.00
+85.00
+(2.35%)
At close: April 4 at 3:30:30 PM GMT+9
Loading Chart for 035610.KQ
  • Previous Close 3,610.00
  • Open 3,575.00
  • Bid 3,650.00 x --
  • Ask 3,660.00 x --
  • Day's Range 3,560.00 - 3,695.00
  • 52 Week Range 3,400.00 - 5,080.00
  • Volume 66,473
  • Avg. Volume 197,723
  • Market Cap (intraday) 94.839B
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Solborn, Inc. engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services. In addition, the company invests in small and medium-sized enterprises and venture companies. Further, it engages in golf related businesses. The company was formerly known as Serome Technology, Inc. Solborn, Inc. was founded in 1994 and is headquartered in Seoul, South Korea.

www.solborn.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 035610.KQ

View More

Performance Overview: 035610.KQ

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

035610.KQ
5.86%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

035610.KQ
23.02%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

035610.KQ
34.14%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

035610.KQ
35.60%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 035610.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 035610.KQ

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    94.84B

  • Enterprise Value

    -60.02B

  • Trailing P/E

    2.18

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.68

  • Price/Book (mrq)

    0.46

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    30.29%

  • Return on Assets (ttm)

    5.42%

  • Return on Equity (ttm)

    23.80%

  • Revenue (ttm)

    121.9B

  • Net Income Avi to Common (ttm)

    38.99B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    158.3B

  • Total Debt/Equity (mrq)

    1.17%

  • Levered Free Cash Flow (ttm)

    30.87B

Research Analysis: 035610.KQ

View More

Company Insights: 035610.KQ

Research Reports: 035610.KQ

View More

People Also Watch